TF and colonic disorder: Both the clinical and non-clinical evidence predominantly asserts the potential of nanoparticles in targeting colonic disorders Nanoparticles like folates, transferrins, aptamers, antibodies, and peptides have attractive properties like the low level of toxicity, biocompatibility, low clearance rates, and controlled drug release.